TREACE MEDICAL CONCEPTS, INC.

Treace Medical Concepts, Inc. is a medical technology company focused on improving surgical treatment for bunion and related midfoot deformities. The company has developed and patented the Lapiplasty® 3D Bunion Correction® System, which includes instruments, implants, and surgical methods designed to correct bunion deformities in three dimensions and stabilize the unstable joint that causes bunions. This system addresses the root cause of bunions, which affect an estimated 67 million Americans, with approximately 1.1 million annual surgical candidates. To further support surgeons and patients, Treace Medical Concepts offers additional systems, including the Adductoplasty® Midfoot Correction System for midfoot correction, the Nanoplasty® 3D Minimally Invasive Bunion Correction System and the Percuplasty™ Percutaneous 3D Bunion Correction® System for minimally invasive osteotomy procedures, and the SpeedMTP® System for great toe fusions. The company is also expanding its SpeedPlate® Rapid Compression Implant platform and provides digital solutions like the IntelliGuide® patient-specific, pre-op planning and cut guide technology. Treace Medical Concepts markets and sells its products in the United States primarily through a direct employee sales force, supplemented by independent sales agencies. These efforts target approximately 8,000 surgical podiatrists and 2,600 orthopedic surgeons specializing in foot and ankle in the United States. The company invests in training and educating physicians on the safe and effective use of its systems. It also runs a direct-to-patient outreach program to educate patients on the Lapiplasty System and other products, including a "Find a Doctor" tool on its website to help patients locate trained surgeons.